Own Pain Relief Solution Store In Your City | Franchise Sales & Distribution Call us on 8691006638
Maintaining adequate progesterone levels is essential in managing high-risk pregnancies and preventing complications like recurrent miscarriage or preterm birth. PROGESTERONE RETARD 500 mg, developed by RIHCA (Rawia International Healthcare), is a high-strength, long-acting formulation designed for intense therapeutic support. Distributed via our global Rawiacare and Rawiacare Global platforms, this product ensures sustained hormonal delivery for superior maternal and fetal care.
Our Mission: To Share • To Care • To Inspire.
PROGESTERONE RETARD RIHCA® 500 mg is specifically engineered for advanced therapeutic hormonal support in high-risk clinical scenarios.
Mechanism of Action: Effectively reduces uterine contractions, supports cervical integrity, and maintains a quiescent uterine environment to enhance pregnancy continuation.
High-Potency Formula: The 500 mg strength provides robust support for patients requiring intensive progesterone therapy.
Clinical Positioning: Specialized for high-risk pregnancy management, recurrent miscarriage prevention, and advanced obstetric care protocols.
| Specifications Table | |
| Parameter | Details |
| Brand Name | PROGESTERONE RETARD RIHCA® |
| Generic Name | Hydroxyprogesterone |
| Arabic Name | بروجستيرون ريتارد ريهكا |
| Category | Hormonal Therapy |
| Therapeutic Area | Women’s Health / Obstetrics & Gynecology |
| Subcategory | Progestins |
| Dosage Form | Injection (Ampoule) |
| Strength / Volume | 500 mg / 2 ml |
| Route / Type | Intramuscular (Depot) |
| Release Type | Long-Acting (Retard) |
| Developed By | RIHCA (Rawia International Healthcare) |
| Distribution Platform | RAWIACARE / RAWIACARE GLOBAL |
| Prevention of preterm birth |
| Management of high-risk pregnancies |
| Support in recurrent miscarriage |
| Progesterone deficiency (moderate to severe) |
| Advanced obstetric care protocols |
| It is used for preventing preterm birth and supporting high-risk pregnancies. |
| Women with high-risk pregnancies or recurrent miscarriage history. |
| It provides higher-dose therapeutic progesterone support. |
| Intramuscular (IM) injection. |
| Yes, under medical supervision. |
